SH3GL1‐activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B‐cell lymphoma
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is predominant subtype of non‐Hodgkin lymphoma and can be effectively treated. Nevertheless, a subset of patients experiences refractory or relapsed disease, highlighting the need for new therapeutic strategies. Methods Depmap database based...
Saved in:
| Main Authors: | Zi‐Wen Duan, Wei‐Ting Wang, Yan Wang, Rong Wang, Wei Hua, Chun‐Yu Shang, Rui Gao, Hao‐Rui Shen, Yue Li, Jia‐Zhu Wu, Hua Yin, Li Wang, Jian‐Yong Li, Wei Xu, Jin‐Hua Liang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Clinical and Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ctm2.70246 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Silibinin attenuates ferroptosis in acute kidney injury by targeting FTH1
by: Yijian Deng, et al.
Published: (2024-11-01) -
METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer
by: Lijie Li, et al.
Published: (2024-12-01) -
Alkbh5 promotes Ythdf1 expression through demethylation thereby facilitating Fth1 translation to inhibit ferroptosis of myocardial infarction
by: Mingnan Yin, et al.
Published: (2025-04-01) -
Mycobacterium tuberculosis modulates NUDT21-mediated alternative polyadenylation to enhance FTH1 expression in macrophages and promotes intracellular growth
by: Xiaoqian Liu, et al.
Published: (2025-05-01) -
Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy
by: Chaofeng Zhang, et al.
Published: (2024-11-01)